The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 06, 2022

Filed:

May. 03, 2018
Applicant:

LA Jolla Institute for Allergy and Immunology, La Jolla, CA (US);

Inventors:

Shane Crotty, San Diego, CA (US);

Jennifer Dan, La Jolla, CA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/09 (2006.01); A61P 37/04 (2006.01); A61P 31/04 (2006.01); A61K 35/17 (2015.01); G01N 33/563 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
A61K 39/092 (2013.01); A61K 35/17 (2013.01); A61P 31/04 (2018.01); A61P 37/04 (2018.01); G01N 33/563 (2013.01); G01N 33/56972 (2013.01); G01N 33/56977 (2013.01); G01N 2800/14 (2013.01); G01N 2800/26 (2013.01); G01N 2800/50 (2013.01); G01N 2800/52 (2013.01);
Abstract

Recurrent tonsillitis disease (RT) is a common indication for pediatric tonsillectomy, the most frequent childhood surgery. It is unknown why some children develop RT. The present disclosure demonstrates that RT tonsils exhibit significantly smaller germinal centers than non-RT tonsils, concomitant with a bias against Group A(GAS)-specific germinal center follicular helper CD4T cells (GC Tfh), and significantly reduced antibodies to the GAS virulence factor SpeA. The present disclosure also shows a significant immunogenetic component to this disease, with the identification of 'at risk' and 'protective' HLA alleles for RT. Finally, the present disclosure identifies a new cell type, granzyme B+GC Tfh cells, which are activated by SpeA, are significantly more abundant in RT GC Tfh cells, and have the capacity to kill B cells, thus, providing a window into the immunology and genetics of a classic childhood disease and identifies a new type of pathogenic T cell.


Find Patent Forward Citations

Loading…